Biostar Pharmaceuticals, Inc. (BSPM) [Rocket]

Overview

Biostar Pharmaceuticals, Inc. (BSPM)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
01/08/2019	25-NSE	Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
08/24/2018	8-K	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial ...
08/23/2018	GN	Biostar Pharmaceuticals Announces Receipt of Additional Delisting Determination Letter from Nasdaq
07/25/2018	8-K	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial ...
07/06/2018	8-K	Other Events
07/02/2018	SC 13D	Liu Waiping reports a 16.2% stake in Biostar Pharmaceuticals, Inc.
05/30/2018	8-K	Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial ...

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13	Dec-31-12	Dec-31-11	Dec-31-10	Dec-31-09
Revenues	2.4	27.1	61.4	52.7	49.3	92.0	0.0	53.3
Revenue growth	-91.2%	-55.8%	16.5%	6.9%	-46.4%		-100.0%	57.2%
Cost of goods sold	1.5	16.0	31.1	27.0	19.5	27.6	0.0	14.3
Gross profit	0.9	11.1	30.3	25.7	29.9	64.4	0.0	39.0
Gross margin	38.4%	40.9%	49.3%	48.7%	60.5%	70.0%		73.2%
Selling, general and administrative							0.0
Sales and marketing	1.2	8.6	18.5	16.6	27.9	38.2	0.0	19.8
Research and development	1.1	4.0	2.8	3.2	4.5	2.3
General and administrative	2.4	4.6	7.7	6.1	7.6	5.7	0.0	4.2
EBIT	-3.6	-15.9	1.3	1.9	-21.8	16.4	0.0	15.1
EBIT margin	-149.5%	-58.7%	2.1%	3.6%	-44.2%	17.8%		28.3%
Pre-tax income	-3.0	-23.8	1.5	2.7	-21.6	18.1	0.0	14.7
Income taxes	2.7	1.3	-3.3	1.8	-1.6	5.9	0.0	4.3
Tax rate				69.5%	7.3%	32.6%		28.8%
Net income	-5.7	-25.1	4.8	0.8	-20.0	12.2	0.0	7.8
Net margin	-239.0%	-92.6%	7.9%	1.5%	-40.5%	13.2%		14.7%

Diluted EPS	($2.48)	($11.36)	$2.34	$0.07	($2.09)	$1.31	$0.00	$0.32
Shares outstanding (diluted)	2.3	2.2	2.1	11.5	9.6	9.3	27.5	24.3

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.